Accelerating antiviral drug discovery: lessons from COVID-19
During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...
主要な著者: | von Delft, A, Hall, MD, Kwong, AD, Purcell, LA, Saikatendu, KS, Schmitz, U, Tallarico, JA, Lee, AA |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Nature
2023
|
類似資料
-
Antiviral research : strategies in antiviral drug discovery /
著者:: LaFemina, Robert L., 等
出版事項: (c200) -
Successful strategies for the discovery of antiviral drugs /
著者:: Desai, Manoj C., 等
出版事項: (2013) -
Glycobiology against viruses: Antiviral drug discovery
著者:: Zitzmann, N, 等
出版事項: (2006) -
Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
著者:: Abdulaziz L, 等
出版事項: (2022-03-01) -
Antiviral drug discovery for emerging diseases and bioterrorism threats /
著者:: Torrence, Paul F.
出版事項: (2005)